Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Why Biogenerics Will Survive Genzyme's Problems
- The Food and Drug Administration rejected Genzyme's request to sell a version of its drug Myozyme made in a new factory, a decision some journalists and bloggers insist on casting as a black mark against the very notion of generic biotech drugs. There's just one problem: These...
- Blog posts 2008-04-22
- Credit Downgrades in Pharma's Future
- Moody's has never been the most cheerful of outfits -- somehow its name seems particularly fitting -- and its latest missive to the drug industry is perfectly in keeping with its dour, green-eyeshade image. In short, pharmaceutical makers need to brace themselves, because their credit problems are only going to...
- Blog posts 2008-06-04
- Pharma Roundup: Change Looms at Sanofi, Children Highly Medicated, and More
- Change coming to Sanofi in 2009; U.S. children taking more drugs than ever before; another state sues Lilly over Zyprexa; Supreme Court hears Wyeth v. Levine arguments. by John Maas
- Blog posts 2008-11-03
Additional Resources
- Breaking Down Obama's Health Care Cuts
- Under President Obama’s budget proposal, about half of the money required to fund his $634 billion “reserve fund†for health reform would come from changes in Medicare and Medicaid spending. Jacob Goldstein of the WSJ Health Blog has dug up a detailed list of these projected savings from 2010-2019 in...
- Blog posts 2009-02-27
- Walgreens Health Clinic Faces Political Trouble In Boston
- A new wrinkle in the debate over retail health clinics is emerging in Massachusetts, where drugstore giant Walgreens is running into political opposition over its plans to open a Take Care clinic in one of its Boston stores. For-profit retail clinics typically offer basic care for minor...
- Blog posts 2008-06-12
- Electronic Medical Records: Bad for Health?
- Electronic medical records could let patients travel freely to doctors of their choice, improve their odds of getting the right care in emergencies and reduce medical errors, duplicated tests and unnecessary prescriptions. They're also the standard in most industrialized nations as well as U.S. healthcare systems such as the Cleveland...
- Blog posts 2008-04-29
- Healthcare Roundup: Aetna-Microsoft Tie-Up, HCS Buys TMG Health, Navigenics Does Sequencing, and More
- Aetna ties up with Microsoft online-health records -- The big health-insurance firm Aetna said it will start allowing many of its members to transfer medical records kept by the insurer to Microsoft's HealthVault, a portable online health-record system. The information in question includes claims, diagnoses, test results and prescriptions. [Source:...
- Blog posts 2008-10-22
- Healthcare Roundup: Possible Health Net Probe, Another Chicago Hospital Closes, ICD-10 Costs Criticized, and More
- Congress calls for investigation of Health Net -- The Woodland, Calif.-based health-insurance company is in the sights of Congress, especially John Dingell, chairman of the House Energy and Commerce Committee. Dingell accuses Health Net of using misleading robocalls to pressure seniors into enrolling for particular Medicare Advantage plans. [Source: Modern...
- Blog posts 2008-10-16
- Healthcare Roundup: Anthem Blue Cross Sued, Hospitals Slow Expansions, GM Cuts Healthcare, and More
- Anthem Blue Cross sued for rescission-settlement efforts -- Los Angeles City Attorney Rocky Delgadillo sued the health-insurance company, a unit of WellPoint, charging that it illegally sought to reach settlements with policyholders by offering them $1,000 in exchange for dropping all legal claims. Anthem and several other health plans recently...
- Blog posts 2008-10-15
- Healthcare Roundup: Aetna's Investment Hit, Hospital Closure Wave, Cigna's Posh New Plans, and More
- Aetna takes an investment hit from financial crisis -- The health-insurance giant said it lost $120 million in its investment portfolio due to widening credit spreads on its fixed-income investments, and took another $70 million hit from its holdings of debt securities issued by the now-defunct Lehman Brothers and Washington...
- Blog posts 2008-10-29
- Cognitive Dissonance on Pharma Ghostwriting
- Yesterday's news on Merck's prolific use of ghostwriters to produce medical-research articles yielded lots of coverage, much of it highly critical. Still, there was a fair bit of cognitive dissonance in the media, which couldn't seem to decide if Merck's actions amounted to venial or mortal sins. ...
- Blog posts 2008-04-17
- Healthcare Roundup: Stent Makers Pay Up, New York Pays Hospitals to Close, and More
- Stent makers forced to pay J&J $1.2BÂ --Â Medtronic and Boston Scientific lost separate patent-infringement cases regarding their bare-metal stents to Johnson & Johnson, and now owe J&J $521 million and $703 million, respectively. Oddly enough, Boston Scientific pulled the offending blood-vessel scaffolds from the market four years ago. [Source:...
- Blog posts 2008-10-02
- Pfizer Spins, And Spins Some More on Chantix
- Last week, Pfizer held its promised "media roundtable" to address a rising chorus of concern about its anti-smoking drug Chantix. Reports from Pharmalot and the WSJ Health Blog suggest that Pfizer and its spokespeople offered exactly the kind of circle-the-wagons defense I'd predicted. From the WSJ blog, Pfizer's main talking...
- Blog posts 2008-06-09
- Pharma Roundup: Roche Insulates Against Suitors, Bristol Faces Problems, and More
- Roche's founding family moves to block acquisitions -- In today's feverish climate of M&A speculation, the descendants of Roche's founder indefinitely extended their majority voting stake in the company. This will make it more difficult for a competitor, like Novartis (which already owns 33 percent of Roche), to swoop in...
- Blog posts 2009-01-28
- Pharma Roundup: Pfizer's Acquisition Plans, Prasugrel's Big Day, and More
- Pfizer CEO seeks big acquisition — In a much-discussed comment to the Financial Times, Pfizer's CEO Jeff Kindler revealed his aspirations for revenue-boosting deals, large and small. As the Health Blog points out, the takeaway here is Kindler's apparent willingness to pursue old-fashioned big acquisitions, at a time when most...
- News items 2009-08-07
- Pharma Roundup: Johnson & Johnson, Abbott, Forest, and More
- An unhappy wind blows through Johnson & Johnson -- Patent expirations are taking their toll on the drug giant, which has seen profits slip and year-over-year sales drop 11 percent. Analysts predict an acquisition. [Source: Forbes, via Corey Nahman] Abbott's diversification brings financial health -- The yin...
- Blog posts 2009-01-21
- Healthcare Roundup: McKesson to Pay $350M, Insurance Consolidation, No Advantage to Advantage Plans, and More
- McKesson agrees to $350M drug-cost settlement -- The major drug and medical-supplies distributor said it will pay $350 million to settle allegations that it conspired to inflate the cost of drugs for consumers and health-insurance providers. McKesson still faces similar lawsuits brought by federal, state and local agencies. [Source: Modern...
- Blog posts 2008-11-28
- Pharma Roundup: Pfizer, Wyeth, Amgen, Bristol, and More
- Pfizer and Wyeth: how many jobs are actually being cut? -- The Health Blog provides a run-down on the various figures that are being tossed around, from 18,000 to 26,000. Their estimate with the math to back it up is 19,425 from the combined company, with at least 8,190 coming...
- Blog posts 2009-01-27
- Pfizer Flails As Chantix Chokes
- When a cash-cow drug like Pfizer's smoking-cessation treatment Chantix comes under fire for alleged side effects, the pharma response always seems to be the same -- circle the wagons and deny, deny, deny. The only problem? Making like the tobacco industry in its heydey doesn't seem to...
- Blog posts 2008-06-02
- Roche-Genentech: The Going Gets Messy
- A quick roundup of recent developments in Roche's dramatic $44 billion bid takeover bid for Genentech: Genentech established a committee of three "independent" directors to evaluate the Roche bid. The especially odd thing here is that one of them is Genentech's co-founder Herbert Boyer. I'm sure Boyer...
- Blog posts 2008-07-27
- << Previous
- page 1 of 1
- Next >>
Presented by the Premiere Rewards Gold Card from American Express